Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Screeners Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Free account open.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 23 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Data quality

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Blog
RSS
Screeners
Newsletter
Key facts
Data
Insider Confidence Index

About
Contact
Pricing
Sign in
Privacy
Terms
Cookies

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-27. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Free account open · Pro on waitlist·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Health Care · InsiderTrades Sigma · page 31

Sector3,940

Health Care

Lixte Biotechnology Holdings, INC.

LogicMark, Inc.

Longeveron Inc.

Longeveron Inc.

Lotus Eye Hospital and Institute Limited

Lucid Diagnostics Inc.

Lucira Health, Inc.

Lumito AB (publ)

Lumito AB (publ)

Lumito AB (publikt)

Lumito AB (publikt)

Lumos Diagnostics Holdings Limited

Lumos Pharma, INC.

Lyell Immunopharma, Inc.

Lyka Labs Limited

Lyra Therapeutics, Inc.

Lytix Biopharma ASA

MAIA Biotechnology, Inc.

MAPS MAPS GROUP: IN THE FIRST HALF, STRONG GROWTH IN PRODUCTS DRIVEN BY THE HEALTHCARE SECTOR. CUSTOM PROJECTS RECORD A DECLINE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MARIA ISABEL LOZANO FERNANDEZ

MASI AGRICOLA MASI AGRICOLA - C.S. ASSEMBLEA STRAORDINARIA DEL 04.03.2024

MBK Wellness Holdings株式会社

MEI Pharma, Inc.

MERCK Kommanditgesellschaft auf Aktien

MOLOGEN Lifescience AG

MPH Health Care AG

MPM Corpóreos S.A.

MSP Recovery, Inc.

Mabwell (Shanghai) Bioscience Co., Ltd. - B

Macrogenics INC

Madrigal Pharmaceuticals, INC.

Magellan Health INC

Previous 1...20...29 303132 33...40 50 60 70...79 Next